Root cause analysis of epidural spinal cord stimulator implant infections with resolution after implementation of an improved protocol for surgical placement.
Neurostimulator
postoperative wound infection
root cause analysis
Journal
Journal of infection prevention
ISSN: 1757-1774
Titre abrégé: J Infect Prev
Pays: England
ID NLM: 101469725
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
21
09
2018
accepted:
19
02
2019
entrez:
21
8
2019
pubmed:
21
8
2019
medline:
21
8
2019
Statut:
ppublish
Résumé
Placing a spinal stimulator for the purpose of restoring paralysed function is a novel procedure; however, paralysis predisposes people to infection. Preventing surgical site infections is critical to benefit this population. The objective of this study was to review the root cause analysis of postoperative wound infections by a hospital epidemiology team following implantation of epidural spinal cord neurostimulators in patients with chronic spinal cord injury. A team was assembled to review the case of every individual who had been enrolled to receive a neurostimulator at the facility. A root cause analysis was performed evaluating five categories: the patient; equipment; facility/environment; procedure; and personnel. The root cause analysis included 11 patients. Two patients became infected. Three others dehisced their wound without becoming infected. All patients were given preoperative antibiotics on time. A mean of 17 personnel were in the operating room during surgery. Vancomycin powder was used in the patients who either dehisced their wound or became infected. The root cause analysis provides guidance for other institutions performing the same novel procedure. This analysis did not reveal a direct association, but did generate several areas for improvement including increasing pre-surgical screening, cleaning transient equipment (e.g., computer screens), limiting traffic in the operating room, using new sterile instruments for each stage of the procedure, not reopening the back incision, not applying vancomycin powder, and using an antimicrobial envelope for the stimulator.
Sections du résumé
BACKGROUND
BACKGROUND
Placing a spinal stimulator for the purpose of restoring paralysed function is a novel procedure; however, paralysis predisposes people to infection. Preventing surgical site infections is critical to benefit this population.
OBJECTIVE
OBJECTIVE
The objective of this study was to review the root cause analysis of postoperative wound infections by a hospital epidemiology team following implantation of epidural spinal cord neurostimulators in patients with chronic spinal cord injury.
METHODS
METHODS
A team was assembled to review the case of every individual who had been enrolled to receive a neurostimulator at the facility. A root cause analysis was performed evaluating five categories: the patient; equipment; facility/environment; procedure; and personnel.
FINDINGS
RESULTS
The root cause analysis included 11 patients. Two patients became infected. Three others dehisced their wound without becoming infected. All patients were given preoperative antibiotics on time. A mean of 17 personnel were in the operating room during surgery. Vancomycin powder was used in the patients who either dehisced their wound or became infected.
CONCLUSIONS
CONCLUSIONS
The root cause analysis provides guidance for other institutions performing the same novel procedure. This analysis did not reveal a direct association, but did generate several areas for improvement including increasing pre-surgical screening, cleaning transient equipment (e.g., computer screens), limiting traffic in the operating room, using new sterile instruments for each stage of the procedure, not reopening the back incision, not applying vancomycin powder, and using an antimicrobial envelope for the stimulator.
Identifiants
pubmed: 31428199
doi: 10.1177/1757177419844323
pii: 10.1177_1757177419844323
pmc: PMC6683604
doi:
Types de publication
Journal Article
Langues
eng
Pagination
185-190Déclaration de conflit d'intérêts
Declaration of conflicting interests: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The following two authors report conflicts of interest: CA reports grants from The Leona M. and Harry B. Helmsley Charitable Trust, grants from US National Institutes of Health, NIBIB, grants from Christopher and Dana Reeve Foundation, grants from Kessler Foundation, grants from Craig H. Neilsen Foundation, non-financial support from University of Louisville Hospital, non-financial support from Medtronic plc, during the conduct of the study. In addition, CA has a patent High Density Epidural Stimulation for Facilitation of Locomotion, Posture, Voluntary Movement, and Recovery of Autonomic, Sexual, Vasomotor and Cognitive Function after Neurological Injury issued, a patent Methods for Applying Epidural Electrical Stimulation pending and a patent Methods for Detecting and Mapping Spinal Cord Epidurally-Evoked Potentials pending. CF reports grants from The Leona M. and Harry B. Helmsley Charitable Trust, grants from US National Institutes of Health, NIBIB, grants from Christopher and Dana Reeve Foundation, grants from Kessler Foundation, grants from Craig H. Neilsen Foundation, non-financial support from University of Louisville Hospital, non-financial support from Medtronic plc, during the conduct of the study. FA, SB, DJ, LS, CH, LO, TB, MS, YC, SH and MB do not report conflicts of interest.
Références
AORN J. 1999 Jun;69(6):1169-72, 1175-7, 1179 passim
pubmed: 10376089
Infect Control Hosp Epidemiol. 2008 Mar;29(3):234-42
pubmed: 18248306
N Engl J Med. 2010 Jan 7;362(1):9-17
pubmed: 20054045
Neurourol Urodyn. 2010;29 Suppl 1:S18-23
pubmed: 20419795
Lancet. 2011 Jun 4;377(9781):1938-47
pubmed: 21601270
Neuromodulation. 2011 Mar-Apr;14(2):136-41; discussion 141
pubmed: 21992200
Pharmacotherapy. 2012 Nov;32(11):1006-19
pubmed: 23124722
Am J Infect Control. 2013 Jul;41(7):629-33
pubmed: 23332373
Spine J. 2014 Mar 1;14(3):397-407
pubmed: 24373682
Brain. 2014 May;137(Pt 5):1394-409
pubmed: 24713270
World Neurosurg. 2015 May;83(5):816-23
pubmed: 25535069
Spine J. 2015 Apr 1;15(4):762-70
pubmed: 25637469
JAMA. 2015 Jun 2;313(21):2162-71
pubmed: 26034956
J Cardiovasc Electrophysiol. 2015 Oct;26(10):1111-6
pubmed: 26222980
Neurosurg Focus. 2015 Oct;39(4):E11
pubmed: 26424335
Neuromodulation. 2016 Jan;19(1):71-84
pubmed: 26490243
Spinal Cord. 2017 Jun;55(6):526-534
pubmed: 27922625
Anesthesiology. 2017 Apr;126(4):585-601
pubmed: 28114178
Neuromodulation. 2017 Aug;20(6):553-557
pubmed: 28726312